Search

Author/Creator Keller, Ralph

2. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial. (February 2021)

Authors:
Kunzmann, Volker; Siveke, Jens T; Algül, Hana; Goekkurt, Eray; Siegler, Gabriele; Martens, Uwe; Waldschmidt, Dirk; Pelzer, Uwe; Fuchs, Martin; Kullmann, Frank; Boeck, Stefan; Ettrich, Thomas J; Held, Swantje; Keller, Ralph; Klein, Ingo; Germer, Christoph-Thomas; Stein, Hubert; Friess, Helmut; Bah...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 6:Number 2(2021)
Page Start:
128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2‐positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group. Issue 6 (29th May 2021)

Authors:
Hofheinz, Ralf‐Dieter; Hegewisch‐Becker, Susanne; Kunzmann, Volker; Thuss‐Patience, Peter; Fuchs, Martin; Homann, Nils; Graeven, Ullrich; Schulte, Nadine; Merx, Kirsten; Pohl, Michael; Held, Swantje; Keller, Ralph; Tannapfel, Andrea; Al‐Batran, Salah‐Eddin
Journal:
International journal of cancer
Issue:
Volume 149:Issue 6(2021)
Page Start:
1322
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗